Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jack A Schalken

Showing results (1-10 of 167) with videos related to

Pageof 17
Sort By:
BJU International|December 20, 2005
Validation of molecular targets in prostate cancerJack A Schalken
Asian Journal of Andrology|March 26, 2013
Urinary biomarkers for prostate cancer: a reviewDaphne Hessels, Jack A Schalken
Nature Reviews. Urology|May 9, 2009
The use of PCA3 in the diagnosis of prostate cancerDaphne Hessels, Jack A Schalken
Current Urology Reports|April 30, 2013
Recurrent gene fusions in prostate cancer: their clinical implications and usesDaphne Hessels, Jack A Schalken
Cancers|November 28, 2013
PCA3 and TMPRSS2-ERG: Promising Biomarkers in Prostate Cancer DiagnosisMaciej Salagierski, Jack A Schalken
The Journal of Urology|January 17, 2012
Molecular diagnosis of prostate cancer: PCA3 and TMPRSS2:ERG gene fusionMaciej Salagierski, Jack A Schalken
European Urology|February 10, 2009
Stem cell characteristics in prostate cancer cell linesMinja J Pfeiffer, Jack A Schalken
Urology|November 11, 2003
Cellular and molecular biology of the prostate: stem cell biologyJack A Schalken, Geert van Leenders
Molecular and Cellular Endocrinology|November 15, 2002
Morphogenic and tumorigenic potentials of the mammary growth hormone/growth hormone receptor systemEvert van Garderen, Jack A Schalken
Central European Journal of Urology|March 1, 2014
How accurate is our prediction of biopsy outcome? PCA3-based nomograms in personalized diagnosis of prostate cancerMaciej Salagierski, Marek Sosnowski, Jack A Schalken
Pageof 17

Showing results (1-10 of 167) with videos related to

Sort By:
Pageof 17
BJU International|December 20, 2005
Validation of molecular targets in prostate cancerJack A Schalken
Asian Journal of Andrology|March 26, 2013
Urinary biomarkers for prostate cancer: a reviewDaphne Hessels, Jack A Schalken
Nature Reviews. Urology|May 9, 2009
The use of PCA3 in the diagnosis of prostate cancerDaphne Hessels, Jack A Schalken
Current Urology Reports|April 30, 2013
Recurrent gene fusions in prostate cancer: their clinical implications and usesDaphne Hessels, Jack A Schalken
Cancers|November 28, 2013
PCA3 and TMPRSS2-ERG: Promising Biomarkers in Prostate Cancer DiagnosisMaciej Salagierski, Jack A Schalken
The Journal of Urology|January 17, 2012
Molecular diagnosis of prostate cancer: PCA3 and TMPRSS2:ERG gene fusionMaciej Salagierski, Jack A Schalken
European Urology|February 10, 2009
Stem cell characteristics in prostate cancer cell linesMinja J Pfeiffer, Jack A Schalken
Urology|November 11, 2003
Cellular and molecular biology of the prostate: stem cell biologyJack A Schalken, Geert van Leenders
Molecular and Cellular Endocrinology|November 15, 2002
Morphogenic and tumorigenic potentials of the mammary growth hormone/growth hormone receptor systemEvert van Garderen, Jack A Schalken
Central European Journal of Urology|March 1, 2014
How accurate is our prediction of biopsy outcome? PCA3-based nomograms in personalized diagnosis of prostate cancerMaciej Salagierski, Marek Sosnowski, Jack A Schalken
Pageof 17